Cortical Plasticity of the Tactile Mirror System in Borderline Personality Disorder (SG2019-EXP2)

March 24, 2026 updated by: Agnese Zazio, IRCCS Centro San Giovanni di Dio Fatebenefratelli

People with borderline personality disorder (BPD) show alterations in the empathic abilities, which may involve the functioning of the mirror neuron system in the somatosensory domain. In the so-called Tactile Mirror System, the observation of a touch on someone else's body activates a cortical network also involved in tactile perception, including the primary somatosensory cortex. While alterations of mirror-like systems have been suggested in BPD, plasticity mechanisms within these systems are underexplored.

The present study aims to shed light on the possible neurophysiological alterations within the Tactile Mirror System in people with BPD, employing a non-invasive transcranial magnetic stimulation protocol, called cross-modal paired associative stimulation (cm-PAS), to induce brain plasticity.

Study Overview

Detailed Description

While previous studies have suggested mirror system alterations in BPD, still little is known about the integrity of a basic neurophysiological mechanism such as brain plasticity within these systems. Considering that the development of mentalization and empathic abilities appears to rely on early associative learning and metaplasticity, it has been suggested that the pathophysiology of BPD may be associated with alterations in neuronal plasticity, mediated by N-methyl-D-aspartate (NMDA) neurotransmission; however, evidence is still lacking. Importantly, the integrity of plasticity mechanisms may represent a critical factor for the effectiveness of therapeutic interventions.

Paired associative stimulation (PAS) protocols represent a well-established tool to non-invasively induce brain plasticity effects in humans. To induce changes in synaptic efficacy, PAS protocols exploit the Hebbian learning rule and the concept of spike-timing dependent plasticity observed at the cellular level, namely that neural connections are strengthened (or weakened) in the case of repeated activations of the presynaptic neuron before the postsynaptic neuron (or vice-versa) in a critical time interval of a few tens of ms. In classical PAS protocols targeting the somatosensory system (S1-PAS), a peripheral electrical stimulus over the wrist (acting as presynaptic activation) is repeatedly paired with a transcranial magnetic stimulation (TMS) pulse over S1 in the contralateral hemisphere (acting as postsynaptic activation). Depending on the time interval between the two stimuli, the S1-PAS may induce long-term potentiation or depression (LTP- or LTD-like, respectively) effects, lasting up to 30 minutes after protocol delivery. In addition to neurophysiological effects (i.e., somatosensory evoked potential modulation), these plastic mechanisms have also been detected by exploiting behavioral measures of S1 functioning, such as tactile acuity.

PAS protocols have also been used to target multisensory integration networks: here, the peripheral and cortical stimuli belong to different systems. Recently, a cross-modal PAS (cm-PAS) has been developed in the visuo-tactile domain, with the aim of targeting the Tactile Mirror System. Compared to classical S1-PAS, in cm-PAS the peripheral electrical stimulus on the wrist is replaced by a visual stimulus of a hand being touched. The efficacy of the cm-PAS in inducing LTP-like mechanisms has been shown in a series of experiments, consisting of an increase in tactile acuity that was specific for the time interval between the visual stimulus and the TMS, for the site of cortical stimulation, and for the content of the visual stimulus. Moreover, cm-PAS modulated a neurophysiological correlate of S1 activity, namely, the amplitude of the P40 component of somatosensory-evoked potentials increased after cm-PAS. Overall, these findings are consistent with the hypothesis that when seeing a human touch on someone else's body, S1 is recruited by mirror-like mechanisms and can be involved in plasticity mechanisms.

Taking together the existing evidence, the present study aims to shed light on the neural basis of interpersonal dysfunction in BPD by bridging the gap between the literature on empathic alterations in BPD patients on the one hand and on the neurophysiological underpinnings of TaMS and its plastic properties in the healthy population on the other hand. Specifically, the integrity of plastic modulations within the Tactile Mirror System will be investigated in BPD patients, by employing the previously described cm-PAS.

The present study will involve BPD 24 patients and 24 healthy controls (HCs) undergoing two sessions of cm-PAS, i.e., an experimental session and a control session. BPD patients will be matched one-to-one with HCs for gender and age. The two groups will be compared in the cognitive dimensions of empathic abilities, measured by means of a self-report questionnaire (Questionnaire for Cognitive and Affective Empathy). To assess the effects of the cm-PAS, both groups will undergo a behavioral task involving visuo-tactile stimuli, before and after the cm-PAS protocol, and performance will be evaluated in terms of accuracy and reaction times.

Study Type

Interventional

Enrollment (Actual)

71

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Brescia
      • Brescia, Brescia, Italy, 25125
        • IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • All participants: right handedness (Edinburgh Handedness Inventory; Oldfield, 1971)
  • Patients group: clinical diagnosis of BPD. The severity of the symptoms will be assessed by means of the Zanarini rating scale for BPD (ZAN-BPD, Zanarini, 2003) and the Symptoms Check-list 90 Revised (SCL-90-R, Derogatis, 1994). Depressive symptoms will be evaluated with the Beck Depression Inventory II (BDI-II, Beck, 1988), impulsiveness with the Barratt Impulsiveness Scale (BIS, Patton, Stanford, & Barratt, 1995), and alexithymia with the Toronto Alexithymia Scale (TAS-20, Bagby, Taylor, & Parker, 1994). Moreover, interpersonal functioning will be evaluated with the Interpersonal Problems (IIP, Pilkonis, Kim, Proietti, & Barkham, 1996), and attachment style will be assessed with the Attachment Style Questionnaire (Feeney, Noller, & Hanrahan, 1994). Finally, the Childhood Trauma Questionnaire (CTQ; Bernstein & Fink, 1998) will be administered for the assessment of traumatic experiences, and the Inventory of statements about self-injury (ISAS, Klonsky & Glenn, 2009) for the evaluation of self-harm.

Exclusion Criteria:

  • All participants: Contraindication to TMS (Rossi et al., 2021)
  • All participants: Anamnesis or evidence of any central nervous system alteration
  • Patients group: Comorbidity with schizophrenia and other psychotic disorders, according to DSM-5, and in case of unstable pharmacological therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental cm-PAS protocol followed by control cm-PAS protocol
Participants will undergo the experimental cm-PAS protocol in the first session of the experiment, followed by the control cm-PAS protocol in the second session. The experimental and the control PAS protocols will differ in the timing of TMS delivery, one effective and the other one uneffective in inducing plastic effects, as shown by previous studies on healthy participants.
The cross-modal Paired Associative Stimulation (cm-PAS) will consist of a visual stimulus depicting a hand being touched repeatedly paired with a transcranial magnetic stimulation (TMS) pulse delivered over the right primary somatosensory area, for a total of 150 paired stimuli delivered at a fixed frequency of 0.1 Hz. The time interval between the visual-touch onset and the TMS pulse will be 20 ms for the experimental session and 100 ms for the control session.
Other Names:
  • TMS
  • transcranial magnetic stimulation
  • PAS
Experimental: Control cm-PAS protocol followed by experimental cm-PAS protocol
Participants will undergo the control cm-PAS protocol in the first session of the experiment, followed by the experimental cm-PAS protocol in the second session. The experimental and the control PAS protocols will differ in the timing of TMS delivery, one effective and the other one uneffective in inducing plastic effects, as shown by previous studies on healthy participants.
The cross-modal Paired Associative Stimulation (cm-PAS) will consist of a visual stimulus depicting a hand being touched repeatedly paired with a transcranial magnetic stimulation (TMS) pulse delivered over the right primary somatosensory area, for a total of 150 paired stimuli delivered at a fixed frequency of 0.1 Hz. The time interval between the visual-touch onset and the TMS pulse will be 20 ms for the experimental session and 100 ms for the control session.
Other Names:
  • TMS
  • transcranial magnetic stimulation
  • PAS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visuo-tactile performance
Time Frame: Within 30 minutes before and after the cm-PAS protocol in each experimental session
Behavioral performance will be obtained from an adapted version of the visuo-tactile spatial congruency task, already used in previous studies to investigate the tactile mirror system. In this task, pictures of a left and a right hand are presented on a screen in egocentric perspective, then, another hand in allocentric perspective appears on the screen and touches either the left or the right hand (i.e., visual touch). At the same time, participants receive a real touch on the left or the right hand, which can be spatially congruent or incongruent with respect to the visual touch. Participants will be asked to report the location of the real touch, i.e., on the left or on the right hand, as fast and accurately as possible, by pressing one of two buttons on a computer keyboard. Both reaction reaction times and accuracy will be considered as outcome measures.
Within 30 minutes before and after the cm-PAS protocol in each experimental session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 4, 2023

Primary Completion (Actual)

November 7, 2025

Study Completion (Actual)

November 7, 2025

Study Registration Dates

First Submitted

November 15, 2024

First Submitted That Met QC Criteria

November 20, 2024

First Posted (Actual)

November 22, 2024

Study Record Updates

Last Update Posted (Actual)

March 27, 2026

Last Update Submitted That Met QC Criteria

March 24, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

  • Behavioral performance (accuracy, reaction times) at the visuo-tactile spatial congruity task, before and after the experimental and the control cm-PAS protocol;
  • Empathic levels as indexed by self-report questionnaire

IPD Sharing Time Frame

Upon acceptance of the scientific paper on study outcome.

IPD Sharing Supporting Information Type

  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Borderline Personality Disorder (BPD)

Clinical Trials on Cross-modal paired associative stimulation (cm-PAS) protocol

Subscribe